Humana Inc. (NYSE:HUM) Shares Acquired by National Bank of Canada FI

National Bank of Canada FI boosted its holdings in Humana Inc. (NYSE:HUM) by 93.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 131,371 shares of the insurance provider’s stock after purchasing an additional 63,545 shares during the period. National Bank of Canada FI owned about 0.11% of Humana worth $61,757,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the business. Morgan Stanley grew its position in shares of Humana by 6.2% during the third quarter. Morgan Stanley now owns 2,040,896 shares of the insurance provider’s stock worth $992,938,000 after buying an additional 119,760 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in Humana by 35.9% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock worth $741,409,000 after acquiring an additional 402,559 shares in the last quarter. Northern Trust Corp increased its position in shares of Humana by 5.1% in the 3rd quarter. Northern Trust Corp now owns 1,327,489 shares of the insurance provider’s stock worth $645,850,000 after purchasing an additional 64,245 shares during the last quarter. Invesco Ltd. raised its stake in shares of Humana by 1.4% in the 3rd quarter. Invesco Ltd. now owns 965,488 shares of the insurance provider’s stock valued at $469,729,000 after purchasing an additional 13,670 shares in the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of Humana by 39.3% during the third quarter. AQR Capital Management LLC now owns 681,868 shares of the insurance provider’s stock worth $331,743,000 after purchasing an additional 192,546 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Activity at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.32% of the company’s stock.

Analyst Ratings Changes

HUM has been the topic of a number of research analyst reports. StockNews.com downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Friday, January 26th. Wells Fargo & Company decreased their price objective on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Stephens reduced their price target on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a research report on Friday, January 26th. Cantor Fitzgerald lowered their price objective on shares of Humana from $391.00 to $360.00 and set a “neutral” rating for the company in a research report on Thursday, April 25th. Finally, UBS Group cut their target price on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a report on Thursday, April 25th. Eleven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $424.50.

Humana Price Performance

Humana stock traded down $0.44 during trading hours on Friday, hitting $320.54. 1,802,675 shares of the company traded hands, compared to its average volume of 1,607,966. The firm’s 50-day simple moving average is $324.12 and its two-hundred day simple moving average is $387.61. The firm has a market cap of $38.63 billion, a P/E ratio of 19.96, a P/E/G ratio of 1.86 and a beta of 0.49. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $541.21. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter last year, the business earned $9.38 earnings per share. As a group, analysts forecast that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.10%. Humana’s dividend payout ratio (DPR) is 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.